“Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

ChrisCashmanPresImage
Chris Cashman of Marinus Pharmaceuticals Inc.   joined us for World Orphan Drug Conference USA 2015 to present about ‘ Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders’ 
Download the presentation to learn about:

  • Ganaxalone: First-In-Class Therapeutic for Epilepsy and Neuropsychiatric Disorders
  • Diversified Clinical Stage Opportunities
  • Behaviors in Fragile X Syndrome
  • Intravenous Formulation

…and much more! 

Get your copy here

 To find out more about Marinus Pharmaceuticals and Gaxalone , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment